Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
02/2007
02/14/2007CN1912115A Venomous snake thrombin sample enzyme modified by polyethylene glycol
02/14/2007CN1912114A Oxygen-enriched catalyst large scale production method of plant erythrocuprein
02/14/2007CN1912113A Protein and nuclein of antrodia camphoratu antioxidase and preparation method and use thereof
02/14/2007CN1300328C Protein hydrol ysater enriched in peptides having a carboxy termina proline residue
02/14/2007CN1300320C Alzhimer's disease secretase
02/14/2007CN1300311C Preparation method of chitin incision enzyme
02/14/2007CN1300310C Low temperature lipase and its coding gene and production method
02/14/2007CN1300309C Microorganic xyloseglukan endotransglycosylation enzyme
02/14/2007CN1300308C New method for picking-up superoxide dismutase from animal blood
02/14/2007CN1300301C 3'-Rhodotorula glutinis fungus of 3'-phosphodiester enzyme and method for preparing 3'-nucleotide
02/14/2007CN1300132C Process for the preparation of 2,4-dideoxyhexoses and 2,4,6-trideoxyhexoses
02/13/2007US7176354 Genes encoding sulfate assimilation proteins
02/13/2007US7176353 Genes encoding sulfate assimilation proteins
02/13/2007US7176350 Method for controlling ratio of proteins/lipids in crop seeds
02/13/2007US7176347 Vegetative growth specific promoter and transgenic plant obtained with the same
02/13/2007US7176345 Rodent model comprising genes coding hypoxia inducible factor (HIF) for detection of hypoxic tissue
02/13/2007US7176299 Compounds
02/13/2007US7176292 Ghrelin variant protein
02/13/2007US7176290 Tau protein epitopes for use in the treatment of alzheimer's disease
02/13/2007US7176288 Human coagulation factor VII variants
02/13/2007US7176285 Ligands for human protein histidine phosphatase (PHP1); identifying agonists and antagonists and treating conditions associated with PHPIP-120 imbalance with the identified compounds; cardiovascular disorders; autism; schizophrenia; antiarthritic and -carcinogenic agents; Bardet-Beidl Syndrome; anemia
02/13/2007US7176281 Phospholipase A2-inhibitory peptide with anti-arthritic and neuroprotective activities
02/13/2007US7176235 10,11-Dehydroepothilones; anticancer, antiproliferative and antiarthritic agents
02/13/2007US7176190 Comprises transgenic potato which generates starch with modified viscosity and phosphate characteristics; for enhancing quality of paper, cardboard, adhesive, textile, plaster, concrete, fertilizer, medicine and toothpaste; improving animal feeds
02/13/2007US7176188 Method of lethally sensitizing human and animal cells
02/13/2007US7176026 Expression of the nucleic acid sequence which codes a protein kinase stresss related polypeptide in the plant results in increased tolerance to environmental stress as compared to a wild type variety of the plant; genetic engineering
02/13/2007US7176019 For modulating NF- kappa B signaling
02/13/2007US7176013 Serine protease variant for use in diagnosis, prevention and treatment of cardiovascular disorders
02/13/2007US7176012 Carboxypeptidase of cocoa
02/13/2007US7176011 Lipid cleavage enzyme
02/13/2007US7176010 Encoded amino acid sequences, DNAs encoding the proteins, recombinant vectors, culturing, drugs comprising the proteins or DNAs, antibodies, drug screening, for arteriosclerosis, hyperlipidemia, obesity or mellitus diabetes
02/13/2007US7176009 Sucrose phosphate synthase
02/13/2007US7176008 Process for producing activated thrombin-activatable fibrinolysis inhibitor
02/13/2007US7176007 RecA mutants
02/13/2007US7176006 Comprises nucleotide sequences coding hydrolase for prodrug therapy; drug screening; drug delivery; detoxification
02/13/2007US7176005 Generating hydrogen gas cleanly via propagation/culturing algae mutant for sulfate permease activity; pollution control and enenrgy
02/13/2007US7175886 Apparatus and method for micron and submicron particle formation
02/13/2007CA2298400C .beta.-fructofuranosidase gene
02/13/2007CA2219962C C3 plants expressing photosynthetic enzyme of c4 plants
02/13/2007CA2219947C Monoclonal antibody reactive to human cetp and assay method for human cetp
02/13/2007CA2084987C Nucleic acid ligands
02/12/2007CA2555979A1 Factor xa-based heparin assay using a heparin-modifying component
02/12/2007CA2553115A1 Modulation of peroxisome proliferation-activated receptors
02/08/2007WO2007016702A2 Chimeric polymerases
02/08/2007WO2007016614A2 Control of sorbose utilization genes and uses thereof
02/08/2007WO2007016221A2 Hyaluronan synthases and methods of making and using same
02/08/2007WO2007015848A2 Improved methods and compositions for increasing longevity and protein yield from a cell culture
02/08/2007WO2007015511A1 D-amino acid oxidase, and method for production of l-amino acid, 2-oxo acid or cyclic imine
02/08/2007WO2007014896A1 Processes for the manufacture of sterilized pancreatin powder
02/08/2007WO2007014740A2 Polynucleotides encoding mhc class i-restricted htert epitopes, analogues thereof or polyepitopes
02/08/2007WO2007014469A1 Hepatitis c antivirals
02/08/2007WO2007014433A1 Polysaccharide synthases
02/08/2007WO2006133182A3 Insect-specific protease recognition sequences
02/08/2007WO2006127452A3 Methods and compositions for modulating the activity of peptidases in macrophage and macrophage-like cells
02/08/2007WO2006067506A3 Hiv resistance genes
02/08/2007WO2005044987A3 Tocopherol associated protein and uses thereof
02/08/2007WO2004108904A3 Porcine cmp-n-acetylneuraminic acid hydroxylase gene
02/08/2007WO2004044124A3 Identification of oligoadenylate synthetase-like genes
02/08/2007US20070033674 Flavanoid 3',5' hydroxylase gene sequences and uses therefor
02/08/2007US20070033663 ES cells having enhanced RNAi effect
02/08/2007US20070032638 Method for the purification of a non-immunoglobulin protein comprising an immunoglobulin-like (ig-like) domain
02/08/2007US20070032445 Antisense IAP nucleobase oligomers and uses thereof
02/08/2007US20070032442 Vector utilizing ribonuclease reductase UTR and use for inhibiting neoplastic cells
02/08/2007US20070032433 Novel peptides as NS3-serine protease inhibitors of hepatitis C virus
02/08/2007US20070032411 Protein kinase signalling
02/08/2007US20070032403 Crystal structure of the ITK kinase domain
02/08/2007US20070032398 Stabilization of granules
02/08/2007US20070031967 Hyperactive, non-phosphorylated, mutant transposases of mariner mobile genetic elements
02/08/2007US20070031965 Chimeric molecules that contain at least one pathogen-detection domain and at least one effector domain; use in preventing or treating a pathogen infection in a cell or organism
02/08/2007US20070031957 Extraction and purification of phosphodiesterase
02/08/2007US20070031956 Crystal structure of human PIM-1 kinase protein complexes and binding pockets thereof, and uses thereof in drug design
02/08/2007US20070031955 Compositions and methods for refolding of denatured proteins
02/08/2007US20070031952 pre-treatment at an elevated temperature below the initial gelatinization temperature of the granular starch followed by simultaneous saccharification and fermentation
02/08/2007US20070031951 Method for the production of resveratrol in a recombinant bacterial host cell
02/08/2007US20070031949 Nitrile hydratase from Amycolatopsis, Actinomadura or Rhodococcus
02/08/2007US20070031948 Shuttle vectors; replicable in bacteria belonging to the genus Rhodococcus and E. coli; permit mass production of useful enzymes including aminoketone asymmetric reductases in transformants
02/08/2007US20070031947 Transgenic amorpha-4, 11-diene synthesis
02/08/2007US20070031945 High mannose proteins and methods of making high mannose proteins
02/08/2007US20070031943 System for manipulating nucleic acids
02/08/2007US20070031928 Glucoamylase variants
02/08/2007US20070031927 Biological system and assay for identifying inhibitors of tubulin glutamylases
02/08/2007US20070031907 Anaplastic lymphoma kinase assay, reagents and compositions thereof
02/08/2007US20070031904 Mammalian IAP gene family, primers, probes and detection methods
02/08/2007US20070031903 Mammalian IAP gene family, primers, probes and detection methods
02/08/2007US20070031899 Using serine/threonine kinase Pim-1 polypeptide phosphorylation inhibition after exposure to modulator as indication of antitumor/cancer activity; treating pancreatic cancer
02/08/2007US20070031879 Novel enterokinase cleavage sequences
02/08/2007US20070031878 Methods and compositions for polypeptide engineering
02/08/2007US20070031872 A141S and G399S mutation in the Omi/HtrA2 protein in Parkinson's disease
02/08/2007US20070031849 Three-dimensional structure of DNA recombination/repair protein and use thereof
02/08/2007US20070031842 379 human secreted proteins
02/08/2007US20070031837 Genetic markers for skatole metabolism
02/08/2007US20070031836 Altered Bacillus SecA comprising at least one amino acid change in IRA-1 and/or IRA-2 (intramolecular regulator of ATP hydrolysis)
02/08/2007US20070031830 Process for the determination of the primary structure of the messenger rna coding for the human recombinant endooligopeptidase a (heopa)(af217798)...
02/08/2007US20070031452 rheumatoid arthritis; nervous system disorders; endogenous retroviral elements (ERV)
02/08/2007US20070031430 Varible domain of heavy chain antibodies; antitumor agents
02/08/2007US20070031422 Selection of cells expressing heteromeric polypeptides
02/08/2007US20070031401 Metalloprotease catalytic site for use in identifying modulators for prevention and treatment of respiratory system disorders
02/08/2007US20070031399 Use of proline specific endoproteases to hydrolyse peptides and proteins
02/08/2007US20070031395 Repressor of skeletal muscle differentiation, nucleic acid coding therefor and the use thereof in diagnosis and therapy
02/08/2007DE19930177B4 Intermolekular assoziierende Verbindungen und deren Verwendung Inter-molecular associative compounds and their use